Odense University Hospital | Svendborg Sygehus - Oncology Department

Odense, Region Syddanmark 5000

3 studies enrolling now · 3 studies all time

What they study most

Advanced Non-small Cell Lung Cancer, HER2 Mutation, Advanced Solid Tumors, HER2 Mutation, MTAP-deleted Solid Tumors

Studies at this site

• A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) — Recruiting now
• A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors — Recruiting now